𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epigenetic loss of CDH1 correlates with multidrug resistance in human hepatocellular carcinoma cells

✍ Scribed by Lei Jiang; Judy Yuet-Wa Chan; Kwok-Pui Fung

Book ID
116303502
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
955 KB
Volume
422
Category
Article
ISSN
0006-291X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Genetic and epigenetic inactivation of T
Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells
✍ David W. Chan; Joyce M.F. Lee; Patrick C.Y. Chan; Irene O.L. Ng πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 529 KB

## Abstract T‐cadherin is an atypical cadherin and growing evidence has indicated that T‐cadherin exerts tumor‐suppressive effects on cancers of epithelial cell type and also causes positive effects on tumor angiogenesis. Human hepatocellular carcinoma (HCC) is a hypervascular tumor and T‐cadherin

Expression of the multidrug resistance p
Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma
✍ Anne T. Nies; JΓΆrg KΓΆnig; Marion Pfannschmidt; Ernst Klar; Walter J. Hofmann; Di πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 1000 KB

Treatment of hepatocellular carcinoma (HCC) by chemotherapy is often impeded by the intrinsic multidrug resistance (MDR) of this frequent primary cancer of the liver. The MDR phenotype can be caused by ATP-dependent export of chemotherapeutic drugs across the plasma membrane being mediated by transp